Efficacy of Ramelteon on Transient Insomnia in Healthy Adults

Summary

The purpose of this study is to evaluate the safety and efficacy of Ramelteon, once daily (QD), in healthy subjects within a sleep lab.

Timeline

Start

2002-12

Primary completion

2003-05

Completion

2003-05

Outcome

Met primary endpoint

paper Ramelteon 8 mg treatment significantly reduced latency to persistent sleep compared with placebo (12.2 min vs. 19.7 min, P=0.004). PMID 18691937 ↗

Publications

• Results Zammit G, Schwartz H, Roth T, Wang-Weigand S, Sainati S, Zhang J. The effects of ramelteon in a first-night model of transient insomnia. Sleep Med. 2009 Jan;10(1):55-9. doi: 10.1016/j.sleep.2008.04.010. Epub 2008 Aug 8.

Drugs

Indications